Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches
about
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches
description
clinical trial
@en
klinisch onderzoek
@nl
name
Lung-MAP: Taselisib as Therapy ...... and Positive Biomarker Matches
@en
type
label
Lung-MAP: Taselisib as Therapy ...... and Positive Biomarker Matches
@en
prefLabel
Lung-MAP: Taselisib as Therapy ...... and Positive Biomarker Matches
@en
P6153
P1050
P1476
A Phase II Study of GDC-0032 ( ...... ng Cancer (Lung-MAP Sub-Study)
@en
P3098
NCT02785913
P580
2014-11-01T00:00:00Z
P582
2017-06-01T00:00:00Z